Mounjaro KwikPen 7.5mg Pre-Filled Pen

Mounjaro KwikPen 7.5mg Solution for Injection in Pre-Filled Pen

Each multiple-dose pre-filled pen contains 4 doses of 0.6ml solution which can be administered. Each dose (0.6ml) contains 7.5mg of tirzepatide.

Mounjaro is indicated:

1. For the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:

• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
• in addition to other medicinal products for the treatment of diabetes.

2. For weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in adults with an initial Body Mass Index (BMI) of:

• ≥ 30 kg/ m2 (obesity) or
• ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Available on request.

Available on request.